Is Danggui Safe to be Taken by Breast Cancer Patients?-A Skepticism Finally Answered by Comprehensive Preclinical Evidence.

Front Pharmacol · 2019 · PMC6604035 · PMID 31293425

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the correlation did not reach statistical significance (p value was 0.071), the information is clear that AS treatment would have potential to stimulate the proliferation of ER-positive breast cancer cells.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.